CRAWFORD & CO
جودة البيانات: 100%
CRD-B
NYSE
Financial Services
Insurance Agents & Brokers
KWD 10.17
▼
KWD 0.37
(-3.51%)
القيمة السوقية: 540.51 M
السعر
KWD 10.54
القيمة السوقية
540.51 M
نطاق اليوم
—
نطاق 52 أسبوعًا
—
حجم التداول
—
فتح —
متوسط 50 يوم / 200 يوم
—
متوسط 50 يوم / 200 يوم
—
Quick Summary
النقاط الرئيسية
Revenue grew 3.57% annually over 5 years — modest growth
Earnings declined -26.18% over the past year
ROE of 10.78% — decent returns on equity
Debt/Equity of 0.11 — conservative balance sheet
Generating 94.83 M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 5.82%
النمو
Revenue Growth (5Y)
3.57%
أقل من متوسط القطاع (5.90%)
Revenue (1Y)-2.25%
Earnings (1Y)-26.18%
FCF Growth (3Y)-2.08%
الجودة
Return on Equity
10.78%
أعلى من متوسط القطاع (9.24%)
ROICN/A
Net Margin1.50%
Op. MarginN/A
الأمان
Debt / Equity
0.11
أقل من متوسط القطاع (0.49)
Current Ratio1.36
Interest CoverageN/A
التقييم
PE (TTM|2027)
27.53 | 9.29
أعلى من متوسط القطاع (11.15)
P/B Ratio2.89
EV/EBITDAN/A
Dividend YieldN/A
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Financial Services (2180 نظير)
مقارنة الأقران
مقابل وسيط قطاع Financial Services (2180 نظير)| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 27.5 | 11.1 |
| P/B | 2.9 | 1.2 |
| ROE % | 10.8 | 9.2 |
| Net Margin % | 1.5 | 9.4 |
| Rev Growth 5Y % | 3.6 | 5.9 |
| D/E | 0.1 | 0.5 |
السعر المستهدف للمحللين
محلل 1
Buy
الحالي
KWD 10.17
المستهدف
KWD 14.00
KWD 14.00
KWD 14.00
KWD 14.00
التوقعات
مكرر الربحية المستقبلي
8.96
ربحية السهم المستقبلية
KWD 1.14
نمو ربحية السهم (تقدير)
+10.7%
الإيرادات المقدّرة
1.37 B
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2027 |
KWD 1.14
KWD 1.12 – KWD 1.15
|
1.37 B | 2 |
| FY2026 |
KWD 1.03
KWD 1.00 – KWD 1.05
|
1.31 B | 2 |
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| 2026 Q2 |
KWD 0.28
KWD 0.26 – KWD 0.29
|
334.00 M | 2 |
| 2026 Q1 |
KWD 0.23
KWD 0.22 – KWD 0.24
|
313.82 M | 2 |
مفاجآت الأرباح
آخر 4 أرباع
| الربع | EPS المقدر | EPS الفعلي | المفاجأة |
|---|---|---|---|
| Q42025 | KWD 0.26 | KWD 0.15 | -42.3% |
| Q32025 | KWD 0.29 | KWD 0.32 | +10.3% |
| Q22025 | KWD 0.25 | KWD 0.22 | -10.2% |
| Q12025 | KWD 0.20 | KWD 0.21 | +5.0% |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -2.25% | Revenue Growth (3Y) | -0.23% |
| Earnings Growth (1Y) | -26.18% | Earnings Growth (3Y) | -19.91% |
| Revenue Growth (5Y) | 3.57% | Earnings Growth (5Y) | -10.57% |
| Profitability | |||
| Revenue (TTM) | 1.31 B | Net Income (TTM) | 19.63 M |
| ROE | 10.78% | ROA | 2.46% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | 1.50% | Free Cash Flow (TTM) | 94.83 M |
| ROIC | N/A | FCF Growth (3Y) | -2.08% |
| Safety | |||
| Debt / Equity | 0.11 | Current Ratio | 1.36 |
| Interest Coverage | N/A | Asset Turnover | 1.64 |
| Working Capital | 97.40 M | Tangible Book Value | 41.94 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 27.53 | Forward P/E | N/A |
| P/B Ratio | 2.89 | P/S Ratio | 0.41 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 17.55% | ||
| Market Cap | 540.51 M | Enterprise Value | 493.02 M |
| Per Share | |||
| EPS (Diluted TTM) | N/A | Revenue / Share | 25.56 |
| FCF / Share | 1.85 | OCF / Share | 1.99 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 0.54% | FCF Conversion | 483.00% |
| SBC-Adj. FCF | 89.01 M | Growth Momentum | -5.82 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.31 B | 1.34 B | 1.32 B | 1.23 B | 1.14 B |
| Net Income | 19.63 M | 26.60 M | 30.61 M | -18.31 M | 30.69 M |
| EPS (Diluted) | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | — | — | — | — | — |
| EBITDA | — | — | — | — | — |
| R&D Expenses | — | — | — | — | — |
| SG&A Expenses | 294.17 M | 299.66 M | 286.51 M | 255.75 M | 244.85 M |
| D&A | 40.04 M | 36.20 M | 35.74 M | 36.10 M | 40.18 M |
| Interest Expense | 14.69 M | 16.86 M | 17.04 M | 10.31 M | 6.56 M |
| Income Tax | 14.92 M | 14.58 M | 17.10 M | 23.58 M | 13.32 M |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 764.30 M | 803.76 M | 799.20 M | 791.51 M | 852.64 M |
| Total Liabilities | — | — | — | — | — |
| Shareholders' Equity | 173.09 M | 157.21 M | 141.62 M | 124.54 M | 211.97 M |
| Total Debt | 227.50 M | 235.80 M | 223.81 M | 265.65 M | 185.30 M |
| Cash & Equivalents | 64.08 M | 55.41 M | 58.36 M | 46.01 M | 53.23 M |
| Current Assets | 352.41 M | 374.23 M | 369.35 M | 351.27 M | 345.92 M |
| Current Liabilities | 309.57 M | 299.73 M | 299.29 M | 279.49 M | 303.86 M |
{"event":"ticker_viewed","properties":{"ticker":"CRD-B","listing_kind":"stock","pathname":"/stocks/crd-b","exchange":"NYSE","country":"US"}}